Alliance Life Sciences Foresees States Following Texas Reporting Guidelines While Waiting for Official Federal Mandates

SOMERSET, N.J.--(BUSINESS WIRE)--Alliance Life Sciences Consulting Group (ALSCG), an innovative management and technology consultancy, announces the release of its White Paper: “Current State of Government Reporting: Will We All Follow Texas?” The paper comes in response to the Centers for Medicare & Medicaid’s (CMS) failure to publish a Proposed AMP Rule for implementing the Medicaid prescription drug provisions of the Patient Protection and Affordable Care Act (PPACA).

“Current State of Government Reporting: Will We All Follow Texas?”

“These guidelines are critical in that they would have a wide-reaching financial impact on the life sciences industry by creating serious administrative and operational challenges,” says Jim Burke, senior vice president, ALSCG. “So, lacking the final rules, we must determine where we stand in the current state of government reporting without official direction. Currently, Texas enacted new regulations, revising and expanding reporting obligations. As we continue to wait, it’s expected that many other states will follow suit as we all wait for official federal mandates to be finalized by CMS.”

In addition to the paper, Darden Paule, senior consultant, ALSCG, will present “A Generic is not a Brand – Differences in Calculations between Generics and Branded Companies” at the 5^th Annual IIR Government Programs Summit, Monday, March 11, 2013 at 11:15 a.m., providing an overview of how generics get to their calculations, and key differences from branded companies.

“Both the White Paper and the Summit presentation exemplify ALSCG’s commitment to helping our customers maximize revenue and optimize pricing in an outcomes-based world,” Burke adds. “Our goal is to help firms receive full value by solving problems in contracting, pricing, reimbursement and commercial operations.”

About ALSCG

Formed in 2001 and headquartered in Somerset, N.J., Alliance Life Sciences Consulting Group helps our customers maximize revenue and pricing in an outcomes-based world. We employ hundreds of professionals around the globe who help firms receive full value by solving problems in Contracting, Pricing, Reimbursement, and Commercial Operations. We enable this mission in a healthcare world where the true focus is on the patient’s health and well-being, the ultimate bottom line for everyone. Alliance works with 8 of the top-10 pharmaceutical manufacturers, as well as mid-market and other life sciences companies. Contact: 866-581-4850 www.alscg.com